For the Inventor, By the Inventor

Enter inventor name

Mark A Gallop

Los Altos, CA, United States of America

Mark A Gallop

USPTO Granted Patents = 107 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 3.2

ph-index = 22

Forward Citations = 2,298(Granted Patents)

Forward Citations (Not Self Cited) = 2,071(Dec 10, 2025)

Inventors with similar research interests:

Location History:

E. Palo Alto, CA (US) (1998 - 2000)
East Palo Alto, CA (US) (1994 - 2002)
Los Altos, CA (US) (1996 - 2012)
Santa Clara, CA (US) (2008 - 2013)
Palo Alto, CA (US) (1997 - 2019)
San Francisco, CA (US) (2018 - 2024)

Company Filing History:

Affymax Technologies, N.v.

Arixa Pharmaceuticals, Inc.

Rubedo Life Sciences, Inc.

Xero Port, Inc.

7. 1 out of 1,168

Glaxo Group Limited

8. 1 out of 15,462

University of California

Arbor Pharmaceuticals, LLC

10. 1 out of 281

Glaxo Wellcome Inc.

11. 1 out of 832,718

Other

patents

Years Active: 1994-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Senolytic Agents

Beta-Lactamase Inhibitors

Prodrugs

Acyloxyalkyl Carbamate

Gaba Analogs

Levodopa Prodrugs

Gemcitabine Prodrugs

Amino Acid Conjugates

Bile-Acid Derived Compounds

Pharmaceutical Compositions

Synthesis Methods

Crystalline Forms

107 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897915 - Sugar derivatives and uses thereof to prepare novel senolytic agents (2024-02-13),

2. 11026963 - Senolytic compositions and uses thereof (2021-06-08),

3. 10722521 - Beta-lactamase inhibitors and uses thereof (2020-07-28),

4. 10500211 - Beta-lactamase inhibitors and uses thereof (2019-12-10),

5. 10385014 - Acyloxyalkyl carbamate prodrugs, methods of synthesis and use (2019-08-20),

6. 10085999 - Beta-lactamase inhibitors and uses thereof (2018-10-02),

7. 9944592 - Acyloxyalkyl carbamate prodrugs, methods of synthesis and use (2018-04-17),

8. 9353057 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2016-05-31),

9. 9238616 - Prodrugs of gaba analogs, compositions and uses thereof (2016-01-19),

10. 8378137 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2013-02-19),

11. 8372881 - Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use (2013-02-12),

12. 8367722 - Methods of using prodrugs of pregabalin (2013-02-05),

13. 8344028 - [object Object] (2013-01-01),

14. 8258179 - Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use (2012-09-04),

15. 8168623 - Prodrugs of GABA analogs, compositions and uses thereof (2012-05-01),

Title: The Innovative Journey of Mark A. Gallop

Introduction: Mark A. Gallop, a visionary inventor based in Los Altos, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mark A. Gallop holds several patents in various technological domains, showcasing his versatility and creativity in innovation. His latest patents focus on cutting-edge solutions in the fields of artificial intelligence and renewable energy.

Career Highlights: With a career spanning over two decades, Mark A. Gallop has established himself as a prominent figure in the tech industry. His innovative approach to problem-solving has led to the development of revolutionary products that have shaped the way we interact with technology today.

Collaborations: Throughout his career, Mark A. Gallop has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His collaborative spirit has been instrumental in pushing the boundaries of technological innovation.

Conclusion: Mark A. Gallop's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His contributions have not only transformed industries but have also inspired the next generation of inventors to push the limits of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…